Today: 21 May 2026
Reckitt Benckiser share price ticks up in London as buyback tranche ends; RKT eyes March results
4 February 2026
1 min read

Reckitt Benckiser share price ticks up in London as buyback tranche ends; RKT eyes March results

London, February 4, 2026, 09:20 GMT — Regular session

  • Shares of Reckitt Benckiser edged up roughly 0.4% in early London trading
  • The company has finished a portion of its £1 billion share buyback and carried out a share consolidation
  • Investors are eyeing next month’s special dividend payout alongside the full-year results

Reckitt Benckiser Group plc shares edged up 0.4% to 6,154 pence during early London trading on Wednesday, tracking the stronger FTSE 100 index.

The stock is reacting to a wave of shareholder returns this week, including a special dividend and a “share consolidation” — a reverse split that reduces the share count but boosts the price per share. Reckitt said the move aims to maintain investors’ proportional ownership largely unchanged following the payout. tools.eurolandir.com

Reckitt announced its new shares began trading at 8 a.m. on Feb. 2, following shareholder approval at a general meeting. The company now has 674,005,752 shares outstanding, with 29,252,346 held in treasury, resulting in 644,753,406 total voting rights.

The company confirmed it has wrapped up the second tranche of its £1 billion share buyback scheme announced last year. Reckitt purchased 3,461,470 shares from Oct. 22 through Jan. 28, paying an average of £59.46 per share. These shares are now held in treasury.

The corporate moves barely stirred the market early this week. Reckitt’s shares climbed 1.1% to 6,159 pence in London on Monday and have gained roughly 16% in the past year, per Alliance News.

For investors, the details count. Treasury shares lack voting rights, and whether a company cancels or holds onto repurchased stock can shift per-share figures over time, even if the business itself stays the same.

Reckitt’s next major event is just around the corner. Their financial calendar lists full-year 2025 results for March 5, with a first-quarter trading update set for April 22.

Still, the capital return won’t provide much protection. A careful view on demand, pricing, or costs in the earnings report will probably carry more weight than the share-count calculations, especially now that the buyback tranche has wrapped up.

Stock Market Today

  • Analysts Boost Broadcom Price Targets Despite Stock Dip
    May 20, 2026, 11:22 PM EDT. Broadcom (AVGO) shares fell 6.5% to $411.07 on May 19, retreating from a record high of $439.79 on May 14. Despite this drop, several major analysts raised their price targets. Wells Fargo lifted its target to $545 from $430, TD Cowen to $500 from $405, and UBS to $490 from $475, all maintaining buy ratings. Evercore ISI's Mark Lipacis, a top-ranked analyst, raised his target to $582, citing growing demand for Broadcom's custom AI chips amid shifts in AI workloads. Risks remain from semiconductor market volatility and geopolitical tensions impacting chip deals. Broadcom's strategic moves, including its VMware acquisition and partnerships with Google and Meta for AI-focused chips, position it well in enterprise infrastructure and AI growth.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Sage Group share price slips again: AI selloff hits SGE.L ahead of AGM
Previous Story

Sage Group share price slips again: AI selloff hits SGE.L ahead of AGM

Adobe stock slips again: ADBE hit by Piper Sandler downgrade as AI disruption fears linger
Next Story

Adobe stock slips again: ADBE hit by Piper Sandler downgrade as AI disruption fears linger

Go toTop